MarketCap
Facebook
X
TelegramQuarterly report 2025-Q2
added 08-04-2025
Glaukos Corporation Retained Earnings 2011-2026 | GKOS
Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.Possible uses include
- reinvestment in development (R&D, equipment, marketing)
- debt repayment
- acquisition of other companies
- creation of reserves for the future
A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.
The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.
Annual Retained Earnings Glaukos Corporation
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -599 M | -464 M | -365 M | -310 M | -190 M | -205 M | -192 M | -192 M | -197 M | -159 M | -147 M | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -147 M | -599 M | -275 M |
Quarterly Retained Earnings Glaukos Corporation
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -783 M | -764 M | -745 M | -690 M | - | -599 M | -562 M | -532 M | -499 M | -464 M | - | - | -360 M | -365 M | -343 M | -350 M | -332 M | -310 M | -310 M | -310 M | -310 M | -190 M | -190 M | -190 M | -190 M | -205 M | -205 M | -205 M | -205 M | -192 M | -192 M | -192 M | -192 M | -192 M | -192 M | -192 M | -192 M | -197 M | -197 M | -197 M | -197 M | -159 M | -159 M | -159 M | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -159 M | -783 M | -317 M |
Retained Earnings of other stocks in the Medical instruments industry
| Issuer | Retained Earnings | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AtriCure
ATRC
|
-413 M | $ 29.85 | 1.05 % | $ 1.43 B |  USA |
 |
AngioDynamics
ANGO
|
-429 M | $ 10.6 | -1.03 % | $ 433 M | USA |
 |
Luminex Corporation
LMNX
|
83.8 M | - | - | $ 1.75 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
-120 M | - | -9.52 % | $ 20.6 M | USA |
 |
Atrion Corporation
ATRI
|
382 K | - | - | $ 810 M | USA |
 |
Harvard Bioscience
HBIO
|
-146 M | $ 0.47 | -4.15 % | $ 19.9 M | USA |
 |
Alcon
ALC
|
19.4 B | $ 77.32 | -1.5 % | $ 40.4 B |  Schweiz |
 |
Antares Pharma, Inc.
ATRS
|
-223 M | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
548 M | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
-11.9 M | - | - | $ 282 M | USA |
 |
ICU Medical
ICUI
|
691 M | $ 125.85 | -2.28 % | $ 3.1 B | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
2.13 B | - | -0.05 % | $ 10.3 B | USA |
 |
InfuSystem Holdings
INFU
|
-59.3 M | $ 9.31 | -0.85 % | $ 192 M | USA |
 |
iRhythm Technologies
IRTC
|
-803 M | $ 113.0 | -1.46 % | $ 3.62 B | USA |
 |
Intuitive Surgical
ISRG
|
7.01 B | $ 472.16 | -1.48 % | $ 169 B | USA |
 |
The Cooper Companies
COO
|
7.64 B | $ 69.92 | -2.24 % | $ 13.9 B | USA |
 |
Varian Medical Systems, Inc.
VAR
|
1.13 B | - | -0.02 % | $ 16.3 B | USA |
 |
Becton, Dickinson and Company
BDX
|
16.6 B | $ 159.36 | -0.17 % | $ 45.8 B | USA |
 |
Haemonetics Corporation
HAE
|
352 M | $ 59.92 | 0.72 % | $ 3.02 B | USA |
 |
electroCore
ECOR
|
-165 M | $ 6.14 | -3.0 % | $ 33.9 K | USA |
 |
Masimo Corporation
MASI
|
1.49 B | $ 175.49 | -0.01 % | $ 9.35 B | USA |
 |
Isoray
ISR
|
-232 M | - | 0.03 % | $ 108 M | USA |
 |
Predictive Oncology
POAI
|
-180 M | - | - | $ 31.1 M | USA |
 |
Ekso Bionics Holdings
EKSO
|
-262 M | $ 11.56 | -2.12 % | $ 28 M | USA |
 |
Repro Med Systems
KRMD
|
-32 M | $ 4.28 | -0.7 % | $ 198 M | USA |
 |
Baxter International
BAX
|
13.7 B | $ 17.4 | -3.36 % | $ 8.93 B | USA |
 |
BioLife Solutions
BLFS
|
-335 M | $ 18.36 | 1.16 % | $ 846 M | USA |
 |
Nephros
NEPH
|
-144 M | $ 3.5 | -7.89 % | $ 36.4 M | USA |
 |
ResMed
RMD
|
3.61 B | $ 230.84 | -0.68 % | $ 33.7 B | USA |
 |
Retractable Technologies
RVP
|
26.7 M | $ 0.71 | 2.62 % | $ 21.3 M | USA |
 |
NeuroMetrix
NURO
|
-218 M | - | 5.05 % | $ 9.02 M | USA |
 |
Merit Medical Systems
MMSI
|
824 M | $ 69.95 | 2.61 % | $ 4.14 B | USA |
 |
Envista Holdings Corporation
NVST
|
-440 M | $ 24.61 | -3.26 % | $ 4.13 B | USA |
 |
STAAR Surgical Company
STAA
|
-148 M | $ 18.84 | 2.45 % | $ 934 M | USA |
 |
Stereotaxis
STXS
|
-583 M | $ 1.89 | 0.27 % | $ 172 M | USA |
 |
Teleflex Incorporated
TFX
|
3.15 B | $ 107.32 | -0.87 % | $ 4.79 B | USA |
 |
OraSure Technologies
OSUR
|
-172 M | $ 2.97 | -3.88 % | $ 218 M | USA |
 |
LeMaitre Vascular
LMAT
|
185 M | $ 108.06 | 1.43 % | $ 2.45 B | USA |
 |
Utah Medical Products
UTMD
|
138 M | $ 63.28 | 1.02 % | $ 230 M | USA |
 |
Pro-Dex
PDEX
|
35.9 M | $ 48.46 | 3.5 % | $ 159 M | USA |
 |
Microbot Medical
MBOT
|
-79.5 M | $ 2.69 | -1.47 % | $ 27.4 M |  Israel |
 |
West Pharmaceutical Services
WST
|
4.37 B | $ 235.46 | 1.89 % | $ 17 B | USA |
 |
Repligen Corporation
RGEN
|
433 M | $ 114.2 | 0.39 % | $ 6.36 M | USA |
 |
DENTSPLY SIRONA
XRAY
|
-1.56 B | $ 11.54 | -2.2 % | $ 2.3 B | USA |
 |
Pulse Biosciences
PLSE
|
-463 M | $ 21.57 | 1.27 % | $ 1.45 B | USA |
 |
STERIS plc
STE
|
2.48 B | $ 214.57 | 1.05 % | $ 21.2 B | USA |
 |
Milestone Scientific
MLSS
|
-128 M | $ 0.28 | -3.75 % | $ 22.3 M | USA |